Education
About Us
Working with TipRanks
Follow Us
Hyperion Defi, Inc. (HYPD)
:HYPD
HYPD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.85 - $124.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)7.06M
Market Cap
$32.81M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.94
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,882,808
10 Day Avg. Volume7,118,483
30 Day Avg. Volume7,057,637
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
Merger And CollaborationThe proposed merger of topical ophthalmic platforms could present the next constructive chapter for Optejet and broader development.
Product DevelopmentCollaborations in dry eye disease development are seen as upside, with the user-filled Optejet potentially defining the most realistic shot for near-term progress.
Technology And InnovationEyenovia’s Optejet ophthalmic spray device is already FDA approved for Mydcombi, which is used for induced pupil dilation for eye exams and related surgery.
Bears Say
Clinical Trial FailuresThe Phase 3 CHAPERONE trial using the Optejet optimized spray dispenser for delivering MicroPine atropine for reduction of pediatric progressive myopia was discontinued.
Market RisksRisks to the investment thesis include failure of products and/or candidates to achieve peak commercial revenue estimates due to market size, penetration rates, and/or pricing.
HYPD FAQ
What was Hyperion Defi, Inc.’s price range in the past 12 months?
Hyperion Defi, Inc. lowest stock price was $0.85 and its highest was $124.80 in the past 12 months.
What is Hyperion Defi, Inc.’s market cap?
Hyperion Defi, Inc.’s market cap is $32.81M.
When is Hyperion Defi, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hyperion Defi, Inc.’s earnings last quarter?
Currently, no data Available
Is Hyperion Defi, Inc. overvalued?
According to Wall Street analysts Hyperion Defi, Inc.’s price is currently Overvalued.
Does Hyperion Defi, Inc. pay dividends?
Hyperion Defi, Inc. does not currently pay dividends.
What is Hyperion Defi, Inc.’s EPS estimate?
Hyperion Defi, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hyperion Defi, Inc. have?
Hyperion Defi, Inc. has 2,882,808 shares outstanding.
What happened to Hyperion Defi, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hyperion Defi, Inc.?
Currently, no hedge funds are holding shares in HYPD
Hyperion DeFi Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-77.14%
Trailing 12-Months
Company Description
Hyperion Defi, Inc.
Eyenovia, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing transformative ophthalmic therapies. The company operates in the biotechnology and pharmaceuticals sectors, with a core focus on creating microdosed medications for eye care using its proprietary Optejet dispenser. Eyenovia's pipeline includes therapies for myopia progression, presbyopia, and pupil dilation.